Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label previous answer version answering member constituency answering member printed answering member
tabling member	label

Search

1504776

registered interest
date	05/09/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Temporary Employment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the total cost to NHS hospitals was of using (a) agency and (b) bank staff in each region in England in the 2021-22 financial year.
tabling member constituency	Enfield North
tabling member printed	Feryal Clark
uin	47698
answer	answer is ministerial correction date of answer 20/09/2022 answer text <p>The information requested is not yet held in the format requested as the accounts for 2021/22 are currently being audited.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 20/09/2022 14:35:04 answering member 4320 label Biography information for Robert Jenrick previous answer version 17726 answering member constituency Suffolk Coastal answering member printed Dr Thérèse Coffey answering member 4098
tabling member	4822 label Biography information for Feryal Clark

1505139

registered interest
date	05/09/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Nurses: Recruitment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he expects eligible post-graduate nurses to receive the £10,000 golden hello payment announced in May 2018.
tabling member constituency	Kingston upon Hull East
tabling member printed	Karl Turner
uin	47512
answer	answer is ministerial correction date of answer 20/09/2022 answer text <p>In May 2018, we announced the intention to pay a ‘golden hello’ to nurses who started a postgraduate course in learning disability nursing, mental health nursing or district nursing in the 2018/19 academic year who subsequently qualified and were employed in these roles in the health and care sector.</p><p>The Government is considering the most effective way to administer and introduce any scheme to ensure it delivers on the original intent.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 20/09/2022 14:37:11 answering member 4320 label Biography information for Robert Jenrick previous answer version 17720 answering member constituency Suffolk Coastal answering member printed Dr Thérèse Coffey answering member 4098
tabling member	4030 label Biography information for Karl Turner

1505163

registered interest
date	05/09/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Tixagevimab/cilgavimab
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he expects NICE's review of Evusheld to be concluded.
tabling member constituency	North Durham
tabling member printed	Mr Kevan Jones
uin	47379
answer	answer is ministerial correction date of answer 20/09/2022 answer text <p>On 10 August 2022, the Department referred tixagevimab and cilgavimab (Evusheld) to the National Institute for Health and Care Excellence (NICE) to evaluate its clinical and cost effectiveness for preventing COVID-19. Between 29 July and 12 August, NICE consulted with stakeholders on the suggested remit, draft scope and list of consultees and commentators.</p><p>NICE has commenced this evaluation and currently expects to publish draft guidance in April 2023, with final guidance to follow in May 2023. In discussion with AstraZeneca, NICE is expediting the appraisal process by bringing forward the deadline for the manufacturer’s evidence submission.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 20/09/2022 14:34:16 answering member 4320 label Biography information for Robert Jenrick previous answer version 17716 answering member constituency Suffolk Coastal answering member printed Dr Thérèse Coffey answering member 4098
tabling member	1438 label Biography information for Mr Kevan Jones